LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care.

    Brinks, Aaltien / van Rijn, Rogier M / Willemsen, Sten P / Bohnen, Arthur M / Verhaar, Jan A N / Koes, Bart W / Bierma-Zeinstra, Sita M A

    Annals of family medicine

    2011  Volume 9, Issue 3, Page(s) 226–234

    Abstract: Purpose: We undertook a study to evaluate the effectiveness of corticosteroid injections in primary care patients with greater trochanteric pain syndrome (GTPS).: Methods: We evaluated the effect of corticosteroid injections compared with expectant ... ...

    Abstract Purpose: We undertook a study to evaluate the effectiveness of corticosteroid injections in primary care patients with greater trochanteric pain syndrome (GTPS).
    Methods: We evaluated the effect of corticosteroid injections compared with expectant treatment (usual care) in a pragmatic, multicenter, open-label, randomized clinical trial in the Netherlands. Patients (aged 18 to 80 years) with GTPS visiting 81 participating primary care physicians were randomly allocated to receive either local corticosteroid injections (n = 60) or usual care (n = 60). Primary outcomes of pain severity (numerical rating scale 0 to 10) and recovery (yes or no total or major recovery) were evaluated at 3-month and 12-month follow-up visits. Adverse events were collected at 6 weeks.
    Results: At the 3-month follow-up visit, 34% of the patients in the usual care group had recovered compared with 55% in the injection group (adjusted OR = 2.38; 95% CI, 1.14-5.00, number needed to treat = 5). Pain severity at rest and on activity decreased in both groups, but the decrease was greater in the injection group, for an adjusted difference in pain at rest of 1.18 (95% CI, 0.31-2.05) and in pain with activity of 1.30 (95% CI, 0.32-2.29). At the 12-month follow-up, 60% of the patients in the usual care group had recovered compared with 61% in the injection group (OR = 1.05; 95% CI, 0.50-2.27). Pain severity at rest and on activity decreased in both groups and the 12-month follow-up showed no significant differences, with adjusted differences of 0.14 (95% CI, -0.75 to 1.04) for pain at rest and 0.45 (95% CI, -0.55 to 1.46) for pain with activity. Aside from a short period with superficial pain at the site of the injection, no differences in adverse events were found.
    Conclusion: In this first randomized controlled trial assessing the effectiveness of corticosteroid injections vs usual care in GTPS, a clinically relevant effect was shown at a 3-month follow-up visit for recovery and for pain at rest and with activity. At a 12-month follow-up visit, the differences in outcome were no longer present.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Arthralgia/drug therapy ; Bursitis/drug therapy ; Bursitis/psychology ; Confidence Intervals ; Female ; Femur/pathology ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Humans ; Injections ; Male ; Middle Aged ; Odds Ratio ; Pain/drug therapy ; Primary Health Care/methods ; Registries ; Treatment Outcome ; Young Adult
    Chemical Substances Glucocorticoids
    Language English
    Publishing date 2011-05-09
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2171425-3
    ISSN 1544-1717 ; 1544-1709
    ISSN (online) 1544-1717
    ISSN 1544-1709
    DOI 10.1370/afm.1232
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Adverse effects of extra-articular corticosteroid injections: a systematic review.

    Brinks, Aaltien / Koes, Bart W / Volkers, Aloysius C W / Verhaar, Jan A N / Bierma-Zeinstra, Sita M A

    BMC musculoskeletal disorders

    2010  Volume 11, Page(s) 206

    Abstract: Background: To estimate the occurrence and type of adverse effects after application of an extra-articular (soft tissue) corticosteroid injection.: Methods: A systematic review of the literature was made based on a PubMed and Embase search covering ... ...

    Abstract Background: To estimate the occurrence and type of adverse effects after application of an extra-articular (soft tissue) corticosteroid injection.
    Methods: A systematic review of the literature was made based on a PubMed and Embase search covering the period 1956 to January 2010. Case reports were included, as were prospective and retrospective studies that reported adverse events of corticosteroid injection. All clinical trials which used extra-articular corticosteroid injections were examined. We divided the reported adverse events into major (defined as those needing intervention or not disappearing) and minor ones (transient, not requiring intervention).
    Results: The search yielded 87 relevant studies:44 case reports, 37 prospective studies and 6 retrospective studies. The major adverse events included osteomyelitis and protothecosis; one fatal necrotizing fasciitis; cellulitis and ecchymosis; tendon ruptures; atrophy of the plantar fat was described after injecting a neuroma; and local skin effects appeared as atrophy, hypopigmentation or as skin defect. The minor adverse events effects ranged from skin rash to flushing and disturbed menstrual pattern. Increased pain or steroid flare after injection was reported in 19 studies. After extra-articular injection, the incidence of major adverse events ranged from 0-5.8% and that of minor adverse events from 0-81%. It was not feasible to pool the risk for adverse effects due to heterogeneity of study populations and difference in interventions and variance in reporting.
    Conclusion: In this literature review it was difficult to accurately quantify the incidence of adverse effects after extra-articular corticosteroid injection. The reported adverse events were relatively mild, although one fatal reaction was reported.
    MeSH term(s) Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Humans ; Musculoskeletal Diseases/drug therapy ; Prospective Studies ; Retrospective Studies
    Chemical Substances Adrenal Cortex Hormones
    Language English
    Publishing date 2010-09-13
    Publishing country England
    Document type Journal Article ; Review ; Systematic Review
    ISSN 1471-2474
    ISSN (online) 1471-2474
    DOI 10.1186/1471-2474-11-206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Adverse effects of extra-articular corticosteroid injections

    Brinks Aaltien / Koes Bart W / Volkers Aloysius CW / Verhaar Jan AN / Bierma-Zeinstra Sita MA

    BMC Musculoskeletal Disorders, Vol 11, Iss 1, p

    a systematic review

    2010  Volume 206

    Abstract: Abstract Background To estimate the occurrence and type of adverse effects after application of an extra-articular (soft tissue) corticosteroid injection. Methods A systematic review of the literature was made based on a PubMed and Embase search covering ...

    Abstract Abstract Background To estimate the occurrence and type of adverse effects after application of an extra-articular (soft tissue) corticosteroid injection. Methods A systematic review of the literature was made based on a PubMed and Embase search covering the period 1956 to January 2010. Case reports were included, as were prospective and retrospective studies that reported adverse events of corticosteroid injection. All clinical trials which used extra-articular corticosteroid injections were examined. We divided the reported adverse events into major (defined as those needing intervention or not disappearing) and minor ones (transient, not requiring intervention). Results The search yielded 87 relevant studies:44 case reports, 37 prospective studies and 6 retrospective studies. The major adverse events included osteomyelitis and protothecosis; one fatal necrotizing fasciitis; cellulitis and ecchymosis; tendon ruptures; atrophy of the plantar fat was described after injecting a neuroma; and local skin effects appeared as atrophy, hypopigmentation or as skin defect. The minor adverse events effects ranged from skin rash to flushing and disturbed menstrual pattern. Increased pain or steroid flare after injection was reported in 19 studies. After extra-articular injection, the incidence of major adverse events ranged from 0-5.8% and that of minor adverse events from 0-81%. It was not feasible to pool the risk for adverse effects due to heterogeneity of study populations and difference in interventions and variance in reporting. Conclusion In this literature review it was difficult to accurately quantify the incidence of adverse effects after extra-articular corticosteroid injection. The reported adverse events were relatively mild, although one fatal reaction was reported.
    Keywords Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences ; Diseases of the musculoskeletal system ; RC925-935
    Subject code 500
    Language English
    Publishing date 2010-09-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Effect of corticosteroid injection for trochanter pain syndrome

    Verhaar Jan AN / Slee Gabriël LJ / Bohnen Arthur M / van Rijn Rogier M / Brinks Aaltien / Koes Bart W / Bierma-Zeinstra Sita MA

    BMC Musculoskeletal Disorders, Vol 8, Iss 1, p

    design of a randomised clinical trial in general practice

    2007  Volume 95

    Abstract: Abstract Background Regional pain in the hip in adults is a common cause of a general practitioner visit. A considerable part of patients suffer from (greater) trochanteric pain syndrome or trochanteric bursitis. Local corticosteroid injections is one of ...

    Abstract Abstract Background Regional pain in the hip in adults is a common cause of a general practitioner visit. A considerable part of patients suffer from (greater) trochanteric pain syndrome or trochanteric bursitis. Local corticosteroid injections is one of the treatment options. Although clear evidence is lacking, small observational studies suggest that this treatment is effective in the short-term follow-up. So far, there are no randomised controlled trials available evaluating the efficacy of injection therapy. This study will investigate the efficacy of local corticosteroid injections in the trochanter syndrome in the general practice, using a randomised controlled trial design. The cost effectiveness of the corticosteroid injection therapy will also be assessed. Secondly, the role of co-morbidity in relation to the efficacy of local corticosteroid injections will be investigated. Methods/Design This study is a pragmatic, open label randomised trial. A total of 150 patients (age 18–80 years) visiting the general practitioner with complaints suggestive of trochanteric pain syndrome will be allocated to receive local corticosteroid injections or to receive usual care. Usual care consists of analgesics as needed. The randomisation is stratified for yes or no co-morbidity of low back pain, osteoarthritis of the hip, or both. The treatment will be evaluated by means of questionnaires at several time points within one year, with the 3 month and 1 year evaluation of pain and recovery as primary outcome. Analyses of primary and secondary outcomes will be made according to the intention-to-treat principle. Direct and indirect costs will be assessed by questionnaires. The cost effectiveness will be estimated using the following ratio: CE ratio = (cost of injection therapy minus cost of usual care)/(effect of injection therapy minus effect of usual care). Discussion This study design is appropriate to estimate effectiveness and cost-effectiveness of the injection therapy. We choose to use a pragmatic study design and are thus not able to study specific effects of the injection with corticosteroids. A distinction between placebo effect of the injection and specific effects of the corticosteroids is therefore not possible. Trial Registration The trial is listed in the Dutch Trial Registry with the number ISRCTN16994576
    Keywords Internal medicine ; RC31-1245 ; Medicine ; R ; DOAJ:Internal medicine ; DOAJ:Medicine (General) ; DOAJ:Health Sciences ; Diseases of the musculoskeletal system ; RC925-935
    Language English
    Publishing date 2007-09-01T00:00:00Z
    Publisher BioMed Central
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Effect of corticosteroid injection for trochanter pain syndrome: design of a randomised clinical trial in general practice.

    Brinks, Aaltien / van Rijn, Rogier M / Bohnen, Arthur M / Slee, Gabriël L J / Verhaar, Jan A N / Koes, Bart W / Bierma-Zeinstra, Sita M A

    BMC musculoskeletal disorders

    2007  Volume 8, Page(s) 95

    Abstract: Background: Regional pain in the hip in adults is a common cause of a general practitioner visit. A considerable part of patients suffer from (greater) trochanteric pain syndrome or trochanteric bursitis. Local corticosteroid injections is one of the ... ...

    Abstract Background: Regional pain in the hip in adults is a common cause of a general practitioner visit. A considerable part of patients suffer from (greater) trochanteric pain syndrome or trochanteric bursitis. Local corticosteroid injections is one of the treatment options. Although clear evidence is lacking, small observational studies suggest that this treatment is effective in the short-term follow-up. So far, there are no randomised controlled trials available evaluating the efficacy of injection therapy. This study will investigate the efficacy of local corticosteroid injections in the trochanter syndrome in the general practice, using a randomised controlled trial design. The cost effectiveness of the corticosteroid injection therapy will also be assessed. Secondly, the role of co-morbidity in relation to the efficacy of local corticosteroid injections will be investigated.
    Methods/design: This study is a pragmatic, open label randomised trial. A total of 150 patients (age 18-80 years) visiting the general practitioner with complaints suggestive of trochanteric pain syndrome will be allocated to receive local corticosteroid injections or to receive usual care. Usual care consists of analgesics as needed. The randomisation is stratified for yes or no co-morbidity of low back pain, osteoarthritis of the hip, or both. The treatment will be evaluated by means of questionnaires at several time points within one year, with the 3 month and 1 year evaluation of pain and recovery as primary outcome. Analyses of primary and secondary outcomes will be made according to the intention-to-treat principle. Direct and indirect costs will be assessed by questionnaires. The cost effectiveness will be estimated using the following ratio: CE ratio = (cost of injection therapy minus cost of usual care)/(effect of injection therapy minus effect of usual care).
    Discussion: This study design is appropriate to estimate effectiveness and cost-effectiveness of the injection therapy. We choose to use a pragmatic study design and are thus not able to study specific effects of the injection with corticosteroids. A distinction between placebo effect of the injection and specific effects of the corticosteroids is therefore not possible.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Arthralgia/drug therapy ; Arthralgia/epidemiology ; Clinical Protocols ; Comorbidity ; Family Practice ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Glucocorticoids/economics ; Hip Joint ; Humans ; Injections, Intra-Articular ; Middle Aged ; Netherlands/epidemiology ; Patient Selection ; Research Design ; Sample Size ; Surveys and Questionnaires ; Treatment Outcome ; Triamcinolone/administration & dosage ; Triamcinolone/adverse effects ; Triamcinolone/economics
    Chemical Substances Glucocorticoids ; Triamcinolone (1ZK20VI6TY)
    Language English
    Publishing date 2007-09-19
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial
    ISSN 1471-2474
    ISSN (online) 1471-2474
    DOI 10.1186/1471-2474-8-95
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top